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Introduction
Why should women care … References
According to the latest statistics from 
the American Cancer Society, 11,995 
women were diagnosed with cervical 
cancer in 2013 and 4,217 women died from 
this cancer (American Cancer Society, 
2016). It is a disease that most often occurs 
in women over 30, and the Center for 
Disease Control (2016) estimates there are 
more than 13,000 new diagnoses each 
year. Scientists have been able to target 
the reason for this disease to a virus called 
the human papillomavirus. Unlike other 
reproductive cancers, cervical cancer is the 
only reproductive cancer that has screening 
available to detect the early stages of 
cellular change in a female’s cervix that can 
lead to cancer; however, not all forms of 
cervical cancer can be detected through 
yearly PAP smear tests and HPV screening 
tests. Ongoing research about this disease, 
encouraging yearly screening and 
education about the signs and symptoms of 
cell change and cervical cancer are 
important in decreasing the deaths related 
to this cancer.
There are two main types of cervical 
cancer. The first one, which accounts for 
about 90% of diagnosed cervical cancers, is 
squamous cell carcinoma that covers the 
cervix (Peate & Jones, 2014, p. 51). The 
second type of cervical cancer is located in 
the gland cells of the endocervix that make 
the mucus and this is called cervical 
adenocarcinoma. According to the 
American Cancer Society (2017), doctors 
are seeing more cases of cervical 
adenocarcinoma in the past 20 to 30 years. 
Lastly, a less common form of cervical 
cancer has features of both squamous cell 
carcinomas and adenocarcinomas called 
adenosquamous carcinomas or mixed 
carcinomas. 
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Pathophysiology 
Significance of Pathophysiology
Knowing certain strains of the human papillomavirus cause about 90% of all 
cervical cancers in women makes it easier for medical professionals to detect and treat 
this type of cancer. Research shows there are two main effective ways to detect the 
virus that can lead to treatment. The first is through cytology-based screening using 
either conventional cervical cytology or Pap smears or a liquid-based cytology that 
involves collecting cell samples from inside a woman’s cervix and then prepping those 
cells on a slide, staining them, reading and reporting (Sherris, et al., 2009). The purpose 
of this testing is to detect precursors of cervical cancer on the epithelial tissue and to 
treat it before it progresses, Sherris, et al. (2009) also cite HPV DNA testing as another 
option which uses cervical or vaginal samples obtained with a brush instead of a swab. 
Their research shows this type of test is more effective in women over the age of 30 
because this age group is at higher risk for precancerous lesions “because of the greater 
likelihood that a positive test result at that age signals a persistent HPV infection” 
leading to cancer (Sherris, et al., 2009, p. 149).
Population Recommendation Grade
Women 21-65(Pap Smear) 
or 30-65 (in combo with 
HPV test)
Screen for cervical cancer 
in ages 21-65 with Pap 
smear evert 3 years. 
Women 30-65 who want 
to lengthen screening 
interval, Pap Smear/HPV 
testing every 5 years
A
Women <30, HPV testing Against screening for
cervical cancer with HPV 
testing, alone or in combo 
with Pap Smear in women 
< 30
D
Women <21 Against screening for 
cervical cancer
D
Women >65, had 
adequate prior screening
Against screening for 
cervical cancer/not high 
risk
D
Women who have had a 
hysterectomy
Against screening for 
cervical cancer/no hx of 
high grade 
lesions/cervical cancer
D
A: USPSTF recommends this service, offer or provide this service D: USPSTF 
recommends against this service, discourage this use of this service. (USPSTF, 2012)
A second major implication for nursing includes the education and promotion of the 
HPV vaccine Gardasil. de Sanjose et al (2017) cite HPV causing “virtually all cervical 
cancer and its immediate precursors everywhere in the world” (p. 452) with HPV 16 and 
HPV 18 subtypes associated with those cancers. Current research shows that by 
vaccinating the female population “could reduce up to 90% of cervical cancer incidence 
worldwide with the existing vaccines” (de Sanjose et al., 2017, p. 452). There are three 
different prophylactic vaccines available with the latest one just released in May 2017. 
The vaccines and guidelines are below (de Sanjose, 2017, p. 453):
Bivalent (16/18)
Quadrivalent (6,11,16, 18)
Nine-Valent (6,11, 16, 18, 31, 33, 45, 52, 58)
Girls vaccinated 9yrs to 14 years – two doses
Girls vaccinated 15 years over – three doses
Boys can be vaccinated following same ages as girls
Why should women care about 
cervical cancer? For one, it is one 
of the cancers, if caught early, 
that can be treated and cured. 
Secondly, because most forms of 
this cancer are caused by one or 
more strains of HPV, it is likely 
many women have already been 
exposed to the virus and do not 
realize it. Bogaards et. al (2010) 
cite in their findings “most 
women will contract at least 1 
high-risk HPV infection during 
their lifetime” (p. 823). Some 
women will have strong enough 
immune systems that can clear 
the HPV infection and will never 
have to face a cancer diagnosis. 
Other women will hear those 
scary three words, “You have 
cancer” and their lives will 
change. Empowering women 
with the information on this 
potentially deadly virus, how it 
invades the female body, how it 
causes cellular change and what 
can be done to prevent it means 
a healthier female population 
worldwide and for generations to 
come. 
The cervix, which is also known as the neck of the womb (Peate & Jones, 2014, p. 
534) is located just below the uterus. The cervical canal is a narrow channel that goes 
from the vagina to the inside of the uterus and normally stays closed except when a 
woman has her menses letting blood flow from the uterus. It also opens to allow 
sperm to travel inside and then has the ability to expand later on during labor and 
birth. 
The cervix has two types of cells that are the focus of cervical cancer. First, the 
cervix is covered with skin-like cells or epithelial cells. Secondly, there are tiny glands 
that line the cervical canal which make mucus and these cells can be susceptible to 
change which can lead to cancer. Research has shown these changes come from the 
human papillomavirus or HPV. 
The human papillomavirus is a group of more than 200 related viruses with 
more than 40 HPV types spread through direct sexual contact, skin to mucous 
infections, vaginal, anal and oral sex (National Cancer Institute, 2015). The sexually 
transmitted HPVs fall into two categories. Low-risk HPVs which are types 6 and 11 
(National Cancer Institute, 2015), do not cause cancer but do cause genital warts. 
There are about a dozen or so high-risk HPVs that can cause cancer but research 
shows types 16 and 18 are responsible for most HPV-caused cancers (National Cancer 
Institute, 2015).
HPV causes cancer by infecting the epithelial cells which line the cervix. Once 
HPV enters the cells, the virus starts making proteins the interfere with cell function. 
The National Cancer Institute (2015) identifies these proteins as E6 and E7 that help 
the cell grow in an “uncontrolled manner and to avoid cell death” (para. 19). Choma 
and McKeaver (2014) suggest differences in cell biology during various stages of a 
female’s life can have an impact “on increasing exposure to the HPV virus” (p. 52). 
They say during puberty the cervical transformation zone, which is where the 
columnar cells meet the squamous cells, shift “outward onto the portio of the cervix” 
and the columnar epithelium gradually changes into squamous epithelium which 
ultimately supports HPV replication because the cells are replicating so fast (Choma & 
McKeaver, 2014, p. 52). 
Signs & 
Symptoms
• Vaginal discharge with 
unpleasant smell (Peate 
& Jones, 2014, p. 535)
• Bloody discharge 
between periods or after 
menopause (ACS, 2017)
• Bleeding after vaginal 
sex, bleeding or spotting 
between periods or after 
douching or pelvic exam 
( ACS, 2017)
• Bleeding after 
menopause strong 
indication of cervical 
cellular change (Walker 
& Hamilton, 2017, p. 6)
• Pain during intercourse 
(Walker & Hamilton, 
2017, p. 6)
Nursing Implications
Cervical cancer was once one of the leading causes of 
cancer deaths among women in the United States, but 
according to the American Cancer Society (2017) those 
numbers have been cut in half because of the increased use 
of the Pap test. This screening allows advanced practitioners 
to find changes in the cervix before it develops into cancer or 
if it is already cancer, catch at an early, curable stage.
Research has shown that education on the HPV virus 
and the need for early and continuous screening is important 
in protecting against and treating cervical cancer. The U.S. 
Preventive Task (2012) latest recommendation on screening 
for women breaks down the population into five different 
categories (see Appendix) for screening and prevention. 
These are the most current recommendations available but 
the U.S. Preventive Task force does say it is currently working 
on updating these guidelines. 
Conclusion
While cervical cancer is not the killer among women it used to be, it is 
still a concern among women ages 21 to 65. Most types of cervical 
cancer are caused by the HPV virus. With the proper screening and 
tests, APNs can detect changes in cervical cells before they become 
invasive cancer. Along with proper screening, patients need to be 
aware of the symptoms associated with this disease. Women must 
understand the importance of bringing these symptoms and any 
other changes they consider “out of the ordinary” to their APN’s 
attention. Such vigilance can lead to catching the disease early, thus 
avoiding invasive treatment and or possibly death.
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